DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹633 Cr | ₹-37 Cr | ₹-278 Cr | ₹-508 Cr | ₹-197 Cr |
What is the latest Total Non-Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹633 Cr |
| Mar2024 | ₹-37 Cr |
| Mar2023 | ₹-278 Cr |
| Mar2022 | ₹-508 Cr |
| Mar2021 | ₹-197 Cr |
How is Total Non-Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹633 Cr | Positive | |
| Mar2024 | ₹-37 Cr | Negative | |
| Mar2023 | ₹-278 Cr | Negative | |
| Mar2022 | ₹-508 Cr | Negative | |
| Mar2021 | ₹-197 Cr | - | |
Compare Total Non-Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹103,085.6 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| MANKIND PHARMA | ₹86,802.6 Cr | -0.7% | -5.7% | -20.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 5.9% |
-3.7% |
-6.5% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses